National Center for Advancing Translational Sciences; Notice of Closed Meetings, 12487 [2015-05304]

Download as PDF 12487 Federal Register / Vol. 80, No. 45 / Monday, March 9, 2015 / Notices TABLE 2—ESTIMATED ANNUAL REPORTING BURDEN 1 One-time (initial) burden ...................................................... Burden from future review ................................................... 1 There 1 1 Average burden per respondent Total annual responses 1 1 1 1 Total hours 80 26 80 26 are no capital costs or operating costs associated with the collection of information. Description of Respondents for Reporting: The final regulation on BSE (73 FR 22720) included a provision that exempts cattle materials prohibited in animal feed (CMPAF) from designated countries from the prohibition on its use in animal feed. A foreign country seeking this designation will submit a written request to FDA that includes a variety of information about the country’s BSE status (§ 589.2001(f)). During the past 6 years, FDA received 2 requests from countries to be exempted from CMPAF restrictions. One-Time (Initial) Reporting Burden There is a one-time burden to countries that apply to FDA seeking to be designated as not subject to restrictions applicable to CMPAF. We estimate that each country that applies for an exclusion will spend 80 hours putting information together to submit to FDA. Table 2 row 1 presents the onetime burden for the exclusion. (See final BSE regulation at 73 FR 22754). Recurring Burden Countries that successfully petition FDA to be designated as exempt from certain BSE-related restrictions applicable to animal feed will be subject to future review by FDA to ensure that their designation remains appropriate. As part of this process, FDA may ask designated countries from time-to-time to confirm that their BSE situation and the information submitted by them in support of their original application remains unchanged. We assume it will take FDA and the designated country undergoing a review in the future about one third the time and effort it did when the information was submitted. Table 2 row 2 presents the expected recurring burden. mstockstill on DSK4VPTVN1PROD with NOTICES Number of responses per respondent Number of respondents 21 CFR section 589.2001(f) Dated: March 2, 2015. Leslie Kux, Associate Commissioner for Policy. [FR Doc. 2015–05356 Filed 3–6–15; 8:45 am] BILLING CODE 4164–01–P VerDate Sep<11>2014 18:04 Mar 06, 2015 Jkt 235001 DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Center for Advancing Translational Sciences; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. App.), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel Small Business Innovation Research (SBIR). Date: March 31, 2015. Time: 8:00 a.m. to 4:00 p.m. Agenda: To review and evaluate grant applications. Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, Bethesda, MD 20817. Contact Person: Rahat Khan, Ph.D., Scientific Review Officer, Office of Scientific Review, National Center for Advancing Translational Sciences, 6701 Democracy Blvd., Rm 1078, Bethesda, MD 20892, 301– 894–7319, khanr2@csr.nih.gov. Name of Committee: National Center for Advancing Translational Sciences Special Emphasis Panel CTSA Meeting 1. Date: April 8–9, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Carol Lambert, Ph.D., Acting Deputy Director, Office of Grants Management & Scientific Review, National Center for Advancing Translational Sciences (NCATS) National Institutes of Health, 6701 Democracy Boulevard, Democracy 1, Room 1076, Bethesda, MD 20892, 301–435–0814, lambert@mail.nih.gov. Name of Committee: National Center for Advancing Translational Sciences Special PO 00000 Frm 00066 Fmt 4703 Sfmt 4703 Emphasis Panel 2015 CTSA Application Review. Date: April 15–16, 2015. Time: 8:00 a.m. to 5:00 p.m. Agenda: To review and evaluate grant applications. Place: Hilton Washington/Rockville 1750 Rockville Pike, Rockville, MD 20852. Contact Person: Guo He Zhang, Ph.D., MPH, Scientific Review Office, Office of Grants Management & Scientific Review, National Center for Advancing Translational Sciences (NCATS) National Institutes of Health, 6701 Democracy Boulevard, Democracy 1, Room 1064, Bethesda, MD 20892, 301–435–0812, zhanggu@ mail.nih.gov. (Catalogue of Federal Domestic Assistance Program Nos. 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.350, B–Cooperative Agreements; 93.859, Biomedical Research and Research Training, National Institutes of Health, HHS). Dated: March 3, 2015. David Clary, Program Analyst, Office of Federal Advisory Committee Policy. [FR Doc. 2015–05304 Filed 3–6–15; 8:45 am] BILLING CODE 4140–01–P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Submission for OMB Review; 30-Day Comment Request Surveys and Interviews To Support an Evaluation of the Innovative Molecular Analysis Technologies (IMAT) Program (NCI) Under the provisions of section 3507(a)(1)(D) of the Paperwork Reduction Act of 1995, the National Institutes of Health (NIH), has submitted to the Office of Management and Budget (OMB) a request for review and approval of the information collection listed below. This proposed information collection was previously published in the Federal Register on December 4, 2014, Vol. 79, Page 72004 and allowed 60-days for public comment. No public comments were received. The purpose of this notice is to allow an additional 30 days for public comment. The National Cancer Institute (NCI), National Institutes of Health, may not conduct or sponsor, and the respondent is not required to respond to, an SUMMARY: E:\FR\FM\09MRN1.SGM 09MRN1

Agencies

[Federal Register Volume 80, Number 45 (Monday, March 9, 2015)]
[Notices]
[Page 12487]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2015-05304]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health


National Center for Advancing Translational Sciences; Notice of 
Closed Meetings

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. App.), notice is hereby given of the following 
meetings.
    The meetings will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5 
U.S.C., as amended. The grant applications and the discussions could 
disclose confidential trade secrets or commercial property such as 
patentable material, and personal information concerning individuals 
associated with the grant applications, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel Small Business Innovation Research 
(SBIR).
    Date: March 31, 2015.
    Time: 8:00 a.m. to 4:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Bethesda Marriott Suites, 6711 Democracy Boulevard, 
Bethesda, MD 20817.
    Contact Person: Rahat Khan, Ph.D., Scientific Review Officer, 
Office of Scientific Review, National Center for Advancing 
Translational Sciences, 6701 Democracy Blvd., Rm 1078, Bethesda, MD 
20892, 301-894-7319, khanr2@csr.nih.gov.

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel CTSA Meeting 1.
    Date: April 8-9, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Carol Lambert, Ph.D., Acting Deputy Director, 
Office of Grants Management & Scientific Review, National Center for 
Advancing Translational Sciences (NCATS) National Institutes of 
Health, 6701 Democracy Boulevard, Democracy 1, Room 1076, Bethesda, 
MD 20892, 301-435-0814, lambert@mail.nih.gov.

    Name of Committee: National Center for Advancing Translational 
Sciences Special Emphasis Panel 2015 CTSA Application Review.
    Date: April 15-16, 2015.
    Time: 8:00 a.m. to 5:00 p.m.
    Agenda: To review and evaluate grant applications.
    Place: Hilton Washington/Rockville 1750 Rockville Pike, 
Rockville, MD 20852.
    Contact Person: Guo He Zhang, Ph.D., MPH, Scientific Review 
Office, Office of Grants Management & Scientific Review, National 
Center for Advancing Translational Sciences (NCATS) National 
Institutes of Health, 6701 Democracy Boulevard, Democracy 1, Room 
1064, Bethesda, MD 20892, 301-435-0812, zhanggu@mail.nih.gov.

(Catalogue of Federal Domestic Assistance Program Nos. 93.859, 
Pharmacology, Physiology, and Biological Chemistry Research; 93.350, 
B-Cooperative Agreements; 93.859, Biomedical Research and Research 
Training, National Institutes of Health, HHS).

    Dated: March 3, 2015.
David Clary,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-05304 Filed 3-6-15; 8:45 am]
 BILLING CODE 4140-01-P

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.